Crosspoint Capital Strategies Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
EXAS
Exact Sciences
EXAS
|
+$3.92M |
| 2 |
SLCA
U.S. SILICA HOLDINGS, INC.
SLCA
|
+$3.79M |
| 3 |
Chord Energy
CHRD
|
+$3.66M |
| 4 |
S
Sprint Corporation
S
|
+$3.5M |
| 5 |
ARRY
Array Biopharma Inc
ARRY
|
+$3.41M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Yelp
YELP
|
+$4.67M |
| 2 |
TAL Education Group
TAL
|
+$4.4M |
| 3 |
PE
PARSLEY ENERGY INC
PE
|
+$4.28M |
| 4 |
NVRO
NEVRO CORP.
NVRO
|
+$4.22M |
| 5 |
NVIDIA
NVDA
|
+$4.21M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.89% |
| 2 | Healthcare | 16.93% |
| 3 | Energy | 14.59% |
| 4 | Financials | 13.29% |
| 5 | Materials | 12.44% |
Similar funds
Crosspoint Capital Strategies's Q4 2016 Portfolio in Review
As of Q4 2016, Crosspoint Capital Strategies held 199 positions worth $113M, up 52% from $73.9M the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Crosspoint Capital Strategies deployed $24.1M of net new capital in Q4 2016, opening 77 new positions and adding to 10 existing holdings. Its largest new stake was Exact Sciences: 242,715 shares worth $3.24M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 16% a quarter earlier, followed by Healthcare and Energy.
On the sell side, the largest reduction was NVIDIA, an estimated $4.21M trimmed.
- Crosspoint Capital Strategies's largest Q4 2016 buy was Exact Sciences: 242,715 shares worth $3.24M.
- Crosspoint Capital Strategies added most to Oclaro Inc. in Q4 2016, an estimated $3.12M increase.
- Crosspoint Capital Strategies's biggest Q4 2016 reduction was NVIDIA, cutting an estimated $4.21M.
- Crosspoint Capital Strategies fully exited Yelp in Q4 2016, selling an estimated $4.67M.
- Crosspoint Capital Strategies's ten largest holdings make up 36% of its $113M portfolio in Q4 2016.
- Crosspoint Capital Strategies opened 77 new positions and closed 75 in Q4 2016.
- Crosspoint Capital Strategies's portfolio value rose 52% quarter-over-quarter to $113M.
Based on Crosspoint Capital Strategies's 13F filing for Q4 2016, filed 23 Jan 2017.